Drug groups
Drugs
Purpose of use in COVID-19
Hypersensitivity reactions
ST, DPT
BAT/ sIgE/ LTT
Desensitization
Anti-cytokine or anti-inflammatory drugs
Tocilizumab
Cytokine storm/MAS
Papular skin lesions133 Delayed urticaria138 Anaphylaxis134,136 DRESS139,140 AGEP142, SJS141 SPT134,136,137 IDT134,136,137 DPT134,136 DIHR131 DNIHR138
Sarilumab Pruritic rash152
Anakinra
ISR144,145 U/Angioedema146 Anaphylaxis147,148 Erythematous plaques149
SPT147,148, IDT147,148
DIHR146,148 DNIHR149
Canakinumab U134
JAK inhibitors Baricitinib Palmoplantar pustulosis157
JAK inhibitors Ruxolitinib morbiliform rash, exfoliative dermatitis156
JAK inhibitors Tofacitinib
U158, palmoplantar pustulosis159
Cyclosporine
Anaphylaxis161-163
SPT161,163 IDT161,163
BAT163
Anti-inflammatory drugs
Glucocorticoids
Cytokine storm/MAS ARDS IHR175-180 NIHR175,176 ACD176 ST175-182, DPT177-182, PT176,186 IDT176,186 DPT176,186 sIgE178,179 BAT178,179
DIHR183,184
Colchicine
Anaphylaxis148 FDE165, MPE166 DPT165 PT167
DNIHR166
Eculizumab
IHR169-171 Anaphylaxis171
SPT171, IDT171
DIHR171
Anti-coagulant or anti-aggregant drugs
Heparin Enoxaparin
Coagulopathy
ISR189 GDE192,193 DRESS195, SJS196 HIT197-199 IHR194,201 SPT205 IDT205 PT205 DPT188,189
BAT201,203,204
DIHR207,208
Dipyridamole
Eczema213 Anaphylaxis214,215
PT213